Biotech Stock Still 700%: What Investors Should Do Today
A biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Learn which cash back cards offer the best deals and rewards. Make the most of your spending with these top choices.
27,977 articlesA biotech stock still 700% has defied gravity, even as it slumps 30% this year. Learn how to read the signals, what a...
Interactive Brokers surged in the first half of 2026 as traders flocked to global markets. This guide breaks down the...
Lumentum Holdings stock zoomed after a positive investor briefing at a major industry conference and a rising price t...
With the Social Security trust fund projected to run dry by 2032, a painful payroll increase could become a central p...
Tether converts a historic $13 billion profit into a bold health-tech investment, backing Eight Sleep at a $1.5 billi...
In his first week as Disney’s leader, Josh D’Amaro confronts three major headwinds that could set the tone for his te...
AI-powered platforms are cutting construction draw timelines dramatically, compressing review cycles from days to hou...
First Advantage stock is climbing today as investors react to better-than-expected results and a growing AI-focused d...
As Turning Point Brands rode a wave of rising oral nicotine sales, one fund made a bold move: trimming a multi-millio...
AMD sits near a pivotal $420 level as first-quarter results underscore strong data-center demand and a bold AI-driven...
A small-cap data services company sparked May’s AI rally, with Innodata surging nearly 150% after a solid earnings re...
XRP is testing a long-running support line that has preceded every major rally since 2014, now coinciding with new ET...